Warrants |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
| Warrants | Warrants
Public Warrants – As of September 30, 2026, there were 11,779,167 Public Warrants outstanding. For every 15,552 Public Warrants, the holder is entitled to purchase one share of Common Stock at a price of $11.50, subject to adjustment. The Public Warrants expire on September 9, 2027, or earlier upon redemption or liquidation. Our Public Warrants are listed on Nasdaq under the symbol “KITTW”.
The Public Warrants, which are accounted for as liabilities in our condensed consolidated balance sheets, were valued as of September 30, 2026 and December 31, 2025 at $8 and $1,612, respectively, based on their publicly-traded price.
For the three months ended September 30, 2026 and 2025, the Company reported a gain in value of Public Warrants of $97 and $30,209, respectively. For the nine months ended September 30, 2026 and 2025 , the Company reported a gain in value of the Public Warrants of $1,604 and $7,511, respectively. The change in fair value of the Public Warrants was reported within other (income) expense in our condensed consolidated statements of operations.
Private Warrants – As of September 30, 2026 there were 4,020,833 Private Warrants outstanding, which are not publicly traded. For every 15,552 Private Warrants, the holder is entitled to purchase one share of Common Stock at an exercise price of $11.50.
The Private Warrants, which are accounted for as liabilities in our condensed consolidated balance sheets, were valued as of September 30, 2026 and December 31, 2025 at $4 and $589, respectively. The fair value of the Private Warrants at September 30, 2026 was estimated using a Black-Scholes option pricing model using the following assumptions: stock price of $1.91, no assumed dividends, a risk-free rate of 4.5%, implied volatility of 318.1%, and a remaining term of 0.94 years. The gain in fair value of the Private Warrants during the three months ended September 30, 2026 and 2025 was $47 and $11,110 , respectively. The gain in fair value of the Private Warrants during the nine months ended September 30, 2026 and 2025 was $585 and $7,312, respectively. The change in fair value of the Private Warrants was reported with other (income) expense in our consolidated statements of operations.
SPA Warrants – As of September 30, 2026, there were 247 SPA warrants outstanding. Each whole SPA Warrant is exercisable for one share of Common Stock.
The SPA Warrants, which are accounted for as liabilities in our condensed consolidated balance sheets, were valued as of September 30, 2026 and December 31, 2025 at $456 and $9,080, respectively, and were estimated using a Black-Scholes valuation model using the following assumptions: stock price $1.23, implied volatility of 152.0%, and remaining term of 6.25 years. The change in the value of the SPA Warrants during the three months ended September 30, 2026 and 2025 was a gain of $1,325 and $62,288 respectively. The change in fair value of SPA Warrants during the nine months ended September 30, 2026 and 2025 was a gain of $8,624 and $130,915 respectively. The change in fair value of SPA Warrants was reported with other (income) expense in our condensed consolidated statements of operations.
|